Company Financials

Royalty Pharma plc Financials

United States dollar

business Royalty Pharma plc Company Profile

Main Stock Listing

NASDAQ: RPRX

Market Capitalization $18.17 Billion as of Jan. 1, 2025

Market Cap History

Valuations Metrics as of Jan. 25, 2025

Trailing PE 12.14
Forward PE 7.03
Price to Sales TTM $8.02
Price to Book MRQ $2.00
Enterprise to Revenue 10.44
Enterprise to EBITDA 15.05

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends 2023-12-31
Most Recent Quarter 2024-09-30
Profit Margin 50.53%
Operating Margin 130.17%
Return on Assets TTM 5.69%
Return on Equity TTM 17.28%

Income Statement

Revenue TTM $2,266,002,944
Revenue per Share TTM $5.06
Quarterly Revenue Growth 5.30%
Gross Profit TTM $1,774,091,008
EBITDA $1,571,586,000
Net Income to Common TTM $1,145,108,992
Diluted EPS TTM $2.54
Quarterly Earnings Growth YoY 654.30%

Balance Sheet

Total Cash MRQ $998,552,000
Total Cash per Share MRQ $2.25
Total Debt MRQ $
Total Debt to Equity MRQ 74.16
Current Ratio MRQ 1.54
Book Value per Share MRQ $15.40

Cash Flow

Operating Cash Flow TTM $2,799,088,896
Levered Free Cash Flow TTM $-2,120,379,520

RPRX Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding 444,302,016
Float Shares 383,872,192
Avg 10 Volume 3,716,677
Avg 30 Volume None
Shares Short 16,557,461
Short Ratio 5.21
Short % of Shares 3.87%
% Held by Insiders 13.17%
% Held by Institutions 72.93%

Stock Price Summary

Beta 0.47
Fifty Two Week Low $24.05
Fifty Two Week High $31.66
Fifty Two Week Change 6.47%
Day 50 MA $26.23
Day 200 MA $27.33

Dividends and Splits

Forward Annual Dividend Rate $0.88
Forward Annual Dividend Yield 2.83%
Trailing Annual Dividend Rate $0.85
Trailing Annual Dividend Yield 2.74%
Payout Ratio 32.68%
Dividend Date 2024-12-10
Ex Dividend Date 2025-02-21
Last Split Factor
Last Split Date